ME News reports that on September 23 (UTC+8), Tesla CEO Elon Musk expressed his optimism about "bio-enhancement" over the next decade, noting that his co-founded company, Neuralink, is working to break through the bottleneck in human information transmission bandwidth. Musk stated that even if AI is sufficiently friendly and willing to serve humans, the speed of information transfer between humans and machines remains too slow. Human bandwidth peaks at approximately 100 bits per second, resulting in extremely low output rates, while computers communicate at trillions of bits per second. Any technology that enhances human communication speed will improve alignment between humans and machines. Otherwise, for an AI communicating at trillions of bits per second, interacting with humans is like humans talking to trees. (Source: ODAILY)
Elon Musk Discusses 'Bio-Enhancement' to Overcome Human Communication Bandwidth Limits
KuCoinFlashShare
Summary
Elon Musk highlighted Neuralink’s role in accelerating human-machine communication, urging bio-enhancements to match AI’s trillion-bit bandwidth. He emphasized that without such upgrades, humans would struggle to keep pace with rapidly evolving systems. Meanwhile, liquidity in crypto markets remains a key focus amid CFT measures, with regulators closely monitoring how emerging technologies like brain interfaces could impact financial flows and compliance.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.